Clareon TruPlus IOLs for Cataracts
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.
Who Is on the Research Team?
Clinical Trial Lead, Surgical
Principal Investigator
Alcon Research, LLC
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative
Participants attend a preoperative visit to prepare for cataract surgery
Surgical
Participants undergo cataract surgery for implantation of Clareon TruPlus Monofocal IOLs
Postoperative
Participants attend postoperative visits to monitor the safety and performance of the IOLs
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Clareon TruPlus Monofocal Non-Toric IOL
- Clareon TruPlus Monofocal Toric IOL
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Implantation with the Clareon TruPlus Monofocal IOL (Non-Toric or Toric) following removal of the clouded natural lens using phacoemulsification
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alcon Research
Lead Sponsor
Raquel C. Bono
Alcon Research
Chief Medical Officer since 2022
MD from Harvard Medical School
David Endicott
Alcon Research
Chief Executive Officer since 2018
MBA from University of Southern California
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.